Treatment | Page 42 of 465 | SpiritIndia.com

Addiction :: New genetic research into nicotine addiction shows promise for personalized treatment

Whether a smoking-cessation drug will enable you to quit smoking may depend on your genes, according to new genotyping research from the Centre for Addiction and Mental Health (CAMH). The study, published in the September issue of the journal Biological Psychiatry, found that the enzyme known to metabolize both the smoking cessation drug bupropion and nicotine is highly genetically variable in all ethnicities and influences smoking cessation.

Cancer :: Cancer Research UK doubles research funding

Cancer Research UK funded a record £315m of research last year. The milestone marks nearly a doubling in research funding since the Charity was formed five years ago, according to its annual report and accounts published today (Friday 14 September 2007).

Tonsil :: Mayo Clinic study finds significant shift in reason for tonsillectomies over last 35 years

A new Mayo Clinic study indicates tonsillectomies are increasingly being performed to treat airway obstructions evidenced by snoring and sleep disorders as opposed to tonsil infections. The study, led by a Mayo Clinic Medical School student, will be presented Sept. 18 at the American Academy of Otolaryngology — Head and Neck Surgery in Washington, D.C.

ADHD :: AHRQ & FDA to study possible heart risks with ADHD medications

Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.

Kidney :: Clinical trials present better alternatives for dialysis patients

Having a healthy kidney is worth a billion dollars. But an unhealthy kidney costs more—about $16 billion more, according to Prabir Roy-Chaudhury, MD, PhD, associate professor in the division of nephrology and hypertension at the University of Cincinnati (UC).

Immunity :: M.D. Anderson-led team reports possible key to autoimmune disease

A human peptide that acts as a natural antibiotic against invading microbes can also bind to the body’s own DNA and trigger an immune response in the absence of an infection, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in an early online publication in Nature.

Diabetes :: JAMA articles do not confirm difference in safety of Avandia and Actos, says GSK

GlaxoSmithKline (NYSE: GSK) believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association (JAMA) do not confirm a difference in the safety profile of Avandia (rosiglitazone) and Actos (pioglitazone).

Cholera :: Number of cholera cases in northern Iraq doubles

The number of people struck by a cholera outbreak in Northern Iraq has doubled to 16,000 people but the death toll remains the same at 10, the United Nations health agency reported.

Health Care :: Mayo Clinic Health Policy Center releases recommendations to advance health care reform

Mayo Clinic Health Policy Center announced 19 recommendations to improve American health care, including a move from employer-based insurance to portable, individual-based coverage.

Ebola :: Ebola virus outbreak in central DR Congo claims 160 lives

At least 160 people have died in an outbreak of the highly lethal haemorrhagic Ebola virus in the centre of the Democratic Republic of the Congo (DRC), the United Nations World Health Organization (WHO) reported, announcing that it is rushing medical and supplies to the region to try to contain the disease.